J B Chemicals and Pharmaceuticals Ltd
Mr. Stewart Barker is the CEO of Biotech Laboratories (Pty) Ltd., a subsidiary of JB Pharma, in South Africa. Mr. Barker brings on board a rich and varied experience across Finance, Manufacturing and Supply Chain, and International Operations. He has worked with large corporations like SA Druggists, now Aspen, and he was also a Director of a Johannesburg Stock Exchange listed IT group where he held the position as the Managing Director of eCommerce. Mr. Barker is a qualified Chartered Accountant (SA) and also holds a Masters in Business Leadership.
This person is not in the org chart
This person is not in any offices
J B Chemicals and Pharmaceuticals Ltd
J. B. Chemicals & Pharmaceuticals Limited is a pharmaceutical company. The Company manufactures and markets a range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredient (APIs). The Company's business segments include domestic formulation business, exports and API business. The Company markets various contrast media products in India, such as Contrapaque (Iohexol), Lek Pamidol (Iopamidol), Trazograf (Diatrazoic acid), Trazogastro - Oral contrast (Diatrazoic acid), Magnilek Injection (Gadopentatic acid) and Cardiolek Injection (Iodixanol). The Company's brands for the Indian pharmaceutical market include Metrogyl (Metronidazole), Nicardia (Nifedipine), Rantac (Ranitidine), Dicloran (Diclofenac Sodium), OF (Ofloxacin), Cilacar (Cilnidipine) and Zecuf herbal. It manufactures generic products for the regulated markets and branded formulations for the emerging markets. It manufactures various APIs, such as Cilnidipine, Diclofenac Acid and Gadopentatic acid.